Cargando…

Effect of oral magnesium sulfate administration on lectin‐like oxidized low‐density lipoprotein receptor‐1 gene expression to prevent atherosclerosis in diabetic rat vessels

AIMS/INTRODUCTION: The purpose of the present study was to investigate the possible effect of oral magnesium sulfate (MgSO (4)) in the reduction of atherosclerosis plaques through inhibition of lectin‐like low‐density lipoprotein receptor‐1 (LOX‐1) gene expression in diabetic vessels. MATERIALS AND...

Descripción completa

Detalles Bibliográficos
Autores principales: Fazlali, Mina, Kharazmi, Fatemeh, Kamran, Mitra, Malekzadeh, Kianoosh, Talebi, Ardeshir, Khosravi, Fatemeh, Soltani, Nepton
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497581/
https://www.ncbi.nlm.nih.gov/pubmed/30328289
http://dx.doi.org/10.1111/jdi.12961
_version_ 1783415485808771072
author Fazlali, Mina
Kharazmi, Fatemeh
Kamran, Mitra
Malekzadeh, Kianoosh
Talebi, Ardeshir
Khosravi, Fatemeh
Soltani, Nepton
author_facet Fazlali, Mina
Kharazmi, Fatemeh
Kamran, Mitra
Malekzadeh, Kianoosh
Talebi, Ardeshir
Khosravi, Fatemeh
Soltani, Nepton
author_sort Fazlali, Mina
collection PubMed
description AIMS/INTRODUCTION: The purpose of the present study was to investigate the possible effect of oral magnesium sulfate (MgSO (4)) in the reduction of atherosclerosis plaques through inhibition of lectin‐like low‐density lipoprotein receptor‐1 (LOX‐1) gene expression in diabetic vessels. MATERIALS AND METHODS: A total of 50 rats were divided into five groups, including non‐diabetic control, Mg‐treated non‐diabetic control, chronic diabetic, Mg‐treated chronic diabetic and insulin‐treated chronic diabetic. The induction of diabetes was carried out by streptozotocin. The Mg‐treated chronic diabetic and Mg‐treated non‐diabetic control groups were treated with 10 g/L of MgSO (4) added to their drinking water. The insulin‐treated chronic diabetic group received 2.5 U/kg of insulin twice per day. The fasting blood glucose level and bodyweight were determined weekly. Blood pressure measurement and the intraperitoneal glucose tolerance test were carried out after 16 weeks, and the plasma levels of Mg, lipid profile and oxidized low‐density lipoprotein cholesterol (oxLDL) were determined. The mesenteric bed was isolated and perfused according to the McGregor method. The aorta was isolated for LOX‐1 genes and proteins expression, and pathological investigation. RESULTS: MgSO (4) administration improved blood pressure, sensitivity to phenylephrine, intraperitoneal glucose tolerance test, lipid profile and plasma ox‐LDL level, and also lowered the blood glucose level to the normal range, and decreased LOX‐1 gene and protein expressions. Insulin decreased blood pressure, sensitivity to phenylephrine, blood glucose, lipid profiles and plasma oxLDL level, but it did not decrease LOX‐1 gene and protein expressions. CONCLUSIONS: The present findings suggested that MgSO (4) improves blood pressure and vessel structure through decreasing oxLDL, and LOX‐1 gene and protein expressions; however, insulin did not repair vessel structure, and LOX‐1 gene and protein expressions.
format Online
Article
Text
id pubmed-6497581
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-64975812019-05-07 Effect of oral magnesium sulfate administration on lectin‐like oxidized low‐density lipoprotein receptor‐1 gene expression to prevent atherosclerosis in diabetic rat vessels Fazlali, Mina Kharazmi, Fatemeh Kamran, Mitra Malekzadeh, Kianoosh Talebi, Ardeshir Khosravi, Fatemeh Soltani, Nepton J Diabetes Investig Articles AIMS/INTRODUCTION: The purpose of the present study was to investigate the possible effect of oral magnesium sulfate (MgSO (4)) in the reduction of atherosclerosis plaques through inhibition of lectin‐like low‐density lipoprotein receptor‐1 (LOX‐1) gene expression in diabetic vessels. MATERIALS AND METHODS: A total of 50 rats were divided into five groups, including non‐diabetic control, Mg‐treated non‐diabetic control, chronic diabetic, Mg‐treated chronic diabetic and insulin‐treated chronic diabetic. The induction of diabetes was carried out by streptozotocin. The Mg‐treated chronic diabetic and Mg‐treated non‐diabetic control groups were treated with 10 g/L of MgSO (4) added to their drinking water. The insulin‐treated chronic diabetic group received 2.5 U/kg of insulin twice per day. The fasting blood glucose level and bodyweight were determined weekly. Blood pressure measurement and the intraperitoneal glucose tolerance test were carried out after 16 weeks, and the plasma levels of Mg, lipid profile and oxidized low‐density lipoprotein cholesterol (oxLDL) were determined. The mesenteric bed was isolated and perfused according to the McGregor method. The aorta was isolated for LOX‐1 genes and proteins expression, and pathological investigation. RESULTS: MgSO (4) administration improved blood pressure, sensitivity to phenylephrine, intraperitoneal glucose tolerance test, lipid profile and plasma ox‐LDL level, and also lowered the blood glucose level to the normal range, and decreased LOX‐1 gene and protein expressions. Insulin decreased blood pressure, sensitivity to phenylephrine, blood glucose, lipid profiles and plasma oxLDL level, but it did not decrease LOX‐1 gene and protein expressions. CONCLUSIONS: The present findings suggested that MgSO (4) improves blood pressure and vessel structure through decreasing oxLDL, and LOX‐1 gene and protein expressions; however, insulin did not repair vessel structure, and LOX‐1 gene and protein expressions. John Wiley and Sons Inc. 2018-12-04 2019-05 /pmc/articles/PMC6497581/ /pubmed/30328289 http://dx.doi.org/10.1111/jdi.12961 Text en © 2018 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Articles
Fazlali, Mina
Kharazmi, Fatemeh
Kamran, Mitra
Malekzadeh, Kianoosh
Talebi, Ardeshir
Khosravi, Fatemeh
Soltani, Nepton
Effect of oral magnesium sulfate administration on lectin‐like oxidized low‐density lipoprotein receptor‐1 gene expression to prevent atherosclerosis in diabetic rat vessels
title Effect of oral magnesium sulfate administration on lectin‐like oxidized low‐density lipoprotein receptor‐1 gene expression to prevent atherosclerosis in diabetic rat vessels
title_full Effect of oral magnesium sulfate administration on lectin‐like oxidized low‐density lipoprotein receptor‐1 gene expression to prevent atherosclerosis in diabetic rat vessels
title_fullStr Effect of oral magnesium sulfate administration on lectin‐like oxidized low‐density lipoprotein receptor‐1 gene expression to prevent atherosclerosis in diabetic rat vessels
title_full_unstemmed Effect of oral magnesium sulfate administration on lectin‐like oxidized low‐density lipoprotein receptor‐1 gene expression to prevent atherosclerosis in diabetic rat vessels
title_short Effect of oral magnesium sulfate administration on lectin‐like oxidized low‐density lipoprotein receptor‐1 gene expression to prevent atherosclerosis in diabetic rat vessels
title_sort effect of oral magnesium sulfate administration on lectin‐like oxidized low‐density lipoprotein receptor‐1 gene expression to prevent atherosclerosis in diabetic rat vessels
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497581/
https://www.ncbi.nlm.nih.gov/pubmed/30328289
http://dx.doi.org/10.1111/jdi.12961
work_keys_str_mv AT fazlalimina effectoforalmagnesiumsulfateadministrationonlectinlikeoxidizedlowdensitylipoproteinreceptor1geneexpressiontopreventatherosclerosisindiabeticratvessels
AT kharazmifatemeh effectoforalmagnesiumsulfateadministrationonlectinlikeoxidizedlowdensitylipoproteinreceptor1geneexpressiontopreventatherosclerosisindiabeticratvessels
AT kamranmitra effectoforalmagnesiumsulfateadministrationonlectinlikeoxidizedlowdensitylipoproteinreceptor1geneexpressiontopreventatherosclerosisindiabeticratvessels
AT malekzadehkianoosh effectoforalmagnesiumsulfateadministrationonlectinlikeoxidizedlowdensitylipoproteinreceptor1geneexpressiontopreventatherosclerosisindiabeticratvessels
AT talebiardeshir effectoforalmagnesiumsulfateadministrationonlectinlikeoxidizedlowdensitylipoproteinreceptor1geneexpressiontopreventatherosclerosisindiabeticratvessels
AT khosravifatemeh effectoforalmagnesiumsulfateadministrationonlectinlikeoxidizedlowdensitylipoproteinreceptor1geneexpressiontopreventatherosclerosisindiabeticratvessels
AT soltaninepton effectoforalmagnesiumsulfateadministrationonlectinlikeoxidizedlowdensitylipoproteinreceptor1geneexpressiontopreventatherosclerosisindiabeticratvessels